Efficacy and safety of switching from adalimumab to baricitinib: Phase 3 data in patients with rheumatoid arthritis
Autor: | Taylor, P, Keystone, E, Ortmann, R, Issa, M, Xie, L, Muram, D, Bradley, J, de Bono, S, Rooney, T, Tanaka, Y |
---|---|
Rok vydání: | 2018 |
Databáze: | OpenAIRE |
Externí odkaz: |